Parallel Advisors LLC Sells 6,797 Shares of Danaher Corporation $DHR

Parallel Advisors LLC cut its position in shares of Danaher Corporation (NYSE:DHR) by 33.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,731 shares of the conglomerate’s stock after selling 6,797 shares during the quarter. Parallel Advisors LLC’s holdings in Danaher were worth $2,603,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after buying an additional 186,584 shares in the last quarter. SeaBridge Investment Advisors LLC bought a new stake in shares of Danaher in the 4th quarter valued at $4,477,000. Legal & General Group Plc lifted its position in shares of Danaher by 1.0% during the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after acquiring an additional 43,169 shares during the period. Robeco Institutional Asset Management B.V. boosted its stake in Danaher by 220.2% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 674,373 shares of the conglomerate’s stock worth $154,377,000 after acquiring an additional 463,764 shares in the last quarter. Finally, Whittier Trust Co. boosted its stake in Danaher by 12.2% during the fourth quarter. Whittier Trust Co. now owns 292,894 shares of the conglomerate’s stock worth $69,296,000 after acquiring an additional 31,790 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

DHR opened at $200.01 on Friday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a market cap of $140.61 billion, a price-to-earnings ratio of 35.53, a PEG ratio of 2.49 and a beta of 0.78. The company’s fifty day moving average price is $190.23 and its two-hundred day moving average price is $194.24. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the company earned $0.77 earnings per share. The business’s revenue was up 5.5% on a year-over-year basis. On average, analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. DZ Bank began coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target for the company. The Goldman Sachs Group cut their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Stifel Nicolaus reduced their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Argus decreased their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Finally, JPMorgan Chase & Co. cut their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.